Zantac Injury Attorneys



Over-the-counter Zantac (Ranitidine) is already one of the largest-selling antacids in the United States. Annual revenue exceeds $125 million. That market share was expected to triple by 2026. Then, the Food and Drug Administration found a dangerously-high level of a cancer-causing compound in Zantac. The watchdog then ordered Sanofi to stop selling the drug in…

https://www.napolilaw.com/article/zantac-injury-attorneys/

Comments

Popular posts from this blog

When Your Employer Does Not Keep Accurate Overtime Records

Doctors Continue To Struggle With Blood Clot Treatment

Untold Truths Behind Cyber Security and Data Breaches